General Information of Xenobiotics (ID: XEO00555)
Xenobiotics Name
Hymecromone
Xenobiotics Type
Pharmaceutical Agent(s)
Classification
Drug in Phase 1 Clinical Trial
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5280567"></iframe>
3D MOL 2D MOL
PubChem CID
5280567
DME(s) Modulated by This Xenobiotics
DME(s) Induced by This Xenobiotics
UDP-glucuronosyltransferase 1A1 (UGT1A1) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 1A10 (UGT1A10) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 1A3 (UGT1A3) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 1A6 (UGT1A6) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 1A7 (UGT1A7) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 1A8 (UGT1A8) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 1A9 (UGT1A9) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 2B15 (UGT2B15) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 2B17 (UGT2B17) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 2B4 (UGT2B4) DME Info Homo sapiens [1]
UDP-glucuronosyltransferase 2B7 (UGT2B7) DME Info Homo sapiens [1]
References
1 Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases. Food Chem Toxicol. 2016 Apr;90:112-22.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.